BACKGROUND: An increasing number of HIV-infected women become pregnant while receiving efavirenz (EFV). We compared the pregnancy outcomes of women exposed to EFV and to nevirapine (NVP) during the first trimester. METHODS: A retrospective study in 4 HIV care centers participating to clinical trials and international cohort collaboration. All HIV-infected pregnant women who conceived on EFV-based or NVP-based antiretroviral therapy (ART) between 2003 and 2009 were included. Pregnancy outcomes were as follows: abortion (voluntary termination), miscarriage [unwanted termination <20 weeks of amenorrhea (WA)], stillborn (death ≥ 20 WA), preterm delivery (live-birth <37 WA), and low birth weight (LBW) (<2500 grams). RESULTS: Overall, 344 HIV-infected pregnant women conceived on ART (213 on EFV and 131 on NVP). Median age was 29 years, and median CD4 count 217 cells per microliter at ART initiation. The overall proportion was 11.7% for abortion, 5.2% for miscarriage, 6.7% for stillborn, 10.8% for preterm delivery, and 20.2% for LBW. There was no difference between EFV and NVP exposure, except for abortion (14.3% vs 7.3%; P = 0.05). No external and visible congenital malformation was observed neither in women exposed to EFV nor in women exposed to NVP. CONCLUSIONS: Among women exposed to EFV, no significant increased risk of unfavorable pregnancy outcome was reported except for abortion.
BACKGROUND: An increasing number of HIV-infectedwomen become pregnant while receiving efavirenz (EFV). We compared the pregnancy outcomes of women exposed to EFV and to nevirapine (NVP) during the first trimester. METHODS: A retrospective study in 4 HIV care centers participating to clinical trials and international cohort collaboration. All HIV-infected pregnant women who conceived on EFV-based or NVP-based antiretroviral therapy (ART) between 2003 and 2009 were included. Pregnancy outcomes were as follows: abortion (voluntary termination), miscarriage [unwanted termination <20 weeks of amenorrhea (WA)], stillborn (death ≥ 20 WA), preterm delivery (live-birth <37 WA), and low birth weight (LBW) (<2500 grams). RESULTS: Overall, 344 HIV-infected pregnant women conceived on ART (213 on EFV and 131 on NVP). Median age was 29 years, and median CD4 count 217 cells per microliter at ART initiation. The overall proportion was 11.7% for abortion, 5.2% for miscarriage, 6.7% for stillborn, 10.8% for preterm delivery, and 20.2% for LBW. There was no difference between EFV and NVP exposure, except for abortion (14.3% vs 7.3%; P = 0.05). No external and visible congenital malformation was observed neither in women exposed to EFV nor in women exposed to NVP. CONCLUSIONS: Among women exposed to EFV, no significant increased risk of unfavorable pregnancy outcome was reported except for abortion.
Authors: Hermann Bussmann; C William Wester; Carolyn N Wester; Bright Lekoko; Okechukwu Okezie; Ann Muir Thomas; S M Victor DeGruttola; Joseph Makhema; Max Essex; Richard G Marlink Journal: J Acquir Immune Defic Syndr Date: 2007-07-01 Impact factor: 3.731
Authors: J Bashi; E Balestre; E Messou; M Maiga; P A Coffie; D M Zannou; O Ba-Gomis; H A Traore; S Eholie; A Minga; P S Sow; E Bissagnene; F Dabis; D K Ekouevi Journal: Med Mal Infect Date: 2009-12-31 Impact factor: 2.152
Authors: M Floridia; E Tamburrini; A Bucceri; C Tibaldi; G Anzidei; G Guaraldi; A Meloni; B Guerra; E Ferrazzi; A Molinari; C Pinnetti; B Salerio; M Ravizza Journal: BJOG Date: 2007-05-15 Impact factor: 6.531
Authors: Eric N Ouattara; Xavier Anglaret; Angela Y Wong; Jennifer Chu; Heather E Hsu; Christine Danel; Serge Eholié; Raoul Moh; Delphine Gabillard; Rochelle P Walensky; Kenneth A Freedberg Journal: AIDS Date: 2012-03-13 Impact factor: 4.177
Authors: Risa M Hoffman; Sean S Brummel; Paula Britto; Jose H Pilotto; Gaerolwe Masheto; Linda Aurpibul; Esau Joao; Murli U Purswani; Shelley Buschur; Marie Flore Pierre; Anne Coletti; Nahida Chakhtoura; Karin L Klingman; Judith S Currier Journal: Clin Infect Dis Date: 2019-01-07 Impact factor: 9.079
Authors: Susie E Huntington; Loveleen K Bansi; Claire Thorne; Jane Anderson; Marie-Louise Newell; Graham P Taylor; Deenan Pillay; Teresa Hill; Pat A Tookey; Caroline A Sabin Journal: AIDS Date: 2011-08-24 Impact factor: 4.177